1. Polar 3-alkylidene-5-pivaloyloxymethyl-5′-hydroxymethyl-γ-lactones as protein kinase C ligands and antitumor agents
- Author
-
Jeewoo Lee, Hwan-Mook Kim, Larry V. Pearce, Shin-Hye Won, Robert J. Surawski, Peter M. Blumberg, Nicholas A. Perry, Chang Woo Lee, Song-Kyu Park, Ji-Hye Kang, Nancy E. Lewin, Yerim Kim, and Daniel J. Lundberg
- Subjects
Stereochemistry ,Clinical Biochemistry ,Pharmaceutical Science ,Antineoplastic Agents ,HL-60 Cells ,Ether ,Ligands ,Pivaloyloxymethyl ,Biochemistry ,Chemical synthesis ,Aldehyde ,Article ,Lactones ,chemistry.chemical_compound ,4-Butyrolactone ,Drug Discovery ,Valerates ,Side chain ,Humans ,Hydroxymethyl ,Molecular Biology ,Protein Kinase C ,chemistry.chemical_classification ,Ligand ,Organic Chemistry ,chemistry ,Molecular Medicine ,K562 Cells ,Lactone - Abstract
A series of DAG-lactones with polar 3-alkylidene substituents have been investigated as PKC-α ligands and antitumor agents. Extensive analysis of structure–activity relationships for the 3-alkylidene chain revealed that polar groups such as ether, hydroxyl, aldehyde, ester, acyloxy, and amido were tolerated with similar binding affinities and reduced lipophilicities compared to the corresponding unsubstituted alkylidene chain. Among the derivatives, compounds 5, 6 and 8 with an ether type of side chain showed high binding affinities in range of Ki = 3–5 nM and excellent antitumor profiles, particularly against the colo205 colon cancer and the K562 leukemia cell lines.
- Published
- 2010